Monivent

What Monivent does

Monivent AB is a Swedish medical device company headquartered in Gothenburg, founded in 2013, that develops products aimed at increasing patient safety for newborn babies requiring assistance to start breathing at birth. Its target end users are neonatal care providers in hospitals and birthing units; the company's underlying expertise sits in the neonatal resuscitation device category, where it is pursuing regulatory clearances (FDA for the US and MDR for the EU) as gating steps to commercialization.

The company's go-to-market is structured around medical-device hardware sales, with a primary emphasis on building international reach through a global distribution partnership that is in active negotiation. To support these commercialization milestones, Monivent has raised a SEK 3.9 million convertible bridge from 16 lenders (including major shareholders and former executives) in October 2024, and has signaled a follow-on rights issue of approximately SEK 13 million contingent on closing the distribution deal. Historical funding has come primarily from Chalmers Ventures AB and Almi Invest.

Operationally, Monivent is a small team (1–10 employees) led by CEO Karin Dahllöf, with co-founder Maria Lindqvist serving in a business development capacity. The company's near-term strategic agenda is dominated by closing the global distribution agreement, advancing FDA and MDR approvals, and securing follow-on capital — a profile consistent with an early-stage, pre-commercial-to-early-commercial medical device business. The firmographic data lists Monivent as public on Stockholm under the ticker sto:MONI, while the funding record describes a privately held company with a convertible-loan structure; this inconsistency is noted but not fully reconciled within the available sources.

Name

Monivent

Legal name

Monivent AB

Website

https://monivent.se

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Monivent AB is a Gothenburg-based medical device company developing neonatal resuscitation products that improve safety for newborn babies needing help to start breathing at birth, currently pursuing FDA/MDR approvals and a global distribution agreement.

Ownership category

akta.pro rank

Product category

Neonatal Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHSAAACAF

Preterm/NICU-Transition Newborn Care (NCS)

Home & Personal Services/Childcare, Babysitting & Nanny Services/Newborn Care Specialist (NCS) Services

Keywords

• Neonatal resuscitation devices
• Newborn ventilation monitoring
• Medical device manufacturing
• Patient safety equipment
• Infant respiratory care

Headquarters

HQ city

Göteborg

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Product Sales: Monivent appears to generate revenue through product sales, likely medical devices given the references to FDA and MDR regulatory approvals.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Monivent develops and manufactures medical devices that increase patient safety for newborn babies requiring help to start breathing at birth. The company's products provide real-time feedback and monitoring during mask ventilation, supporting clinicians during neonatal resuscitation. The devices are intended for use in delivery rooms and neonatal care settings to improve outcomes during the critical first minutes of life.

Differentiator

Problem solved

Functional benefit

Products and services

• Neonatal Resuscitation Feedback Device

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Global Distribution Partner (unnamed)coreChannel Partner/ Reseller/ Distributor · 1 January 2024Monivent is in active negotiations to secure a global distribution agreement. This partnership is intended to enable international market expansion for their medical device products. The bridge financing and planned rights issue are partly structured to support the closing of this distribution deal.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• GE HealthCare: GE HealthCare is a large incumbent in medical imaging, monitoring, and neonatal care, offering products that span delivery-room and NICU workflows. As a broad medtech player with established hospital relationships, it represents both a competitor and a potential channel for Monivent-style devices.
• Dräger: Dräger is a large medical and safety technology company with an extensive neonatal care portfolio including resuscitators, warming therapy, and NICU ventilation. It competes with Monivent in delivery-room neonatal resuscitation and is a likely competitor on hospital procurement lists.
• Medtronic: Medtronic is a global medtech incumbent with a broad respiratory and patient monitoring portfolio that overlaps with Monivent's hospital customer base. While not specialized in neonatal resuscitation, it is a relevant competitor on hospital procurement bids.
• Koninklijke Philips: Philips is a broad incumbent in patient monitoring and respiratory care with neonatal care offerings and global hospital sales channels. It competes with Monivent at the high end of the neonatal care market and is a useful comparable for global commercial scale.

Direct peers

• Vyaire Medical: Vyaire Medical specializes in respiratory care products including infant resuscitation devices. It is a direct peer competing for the same hospital delivery-room and NICU procurement budgets as Monivent.
• Laerdal Medical: Laerdal Medical is a global leader in resuscitation training and equipment, with a dedicated neonatal resuscitation portfolio (e.g., NeoNatalie, Upright resuscitator). It is the most direct comparable to Monivent given its focus on newborn breathing assistance and clinical safety in delivery rooms.
• Ambu: Ambu is a global medical device company with a strong respiratory and anesthesia portfolio that includes products relevant to neonatal airway management. It is comparable to Monivent as a hospital-focused respiratory device specialist selling into similar clinical workflows.
• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare manufactures respiratory care products including neonatal resuscitation and ventilation systems sold to hospitals globally. It is a direct competitor in the neonatal respiratory care category that Monivent targets.
• Inspiration Healthcare: Inspiration Healthcare is a UK-based medical technology company focused on neonatal intensive care and operating theatre products, including neonatal resuscitation and respiratory support devices. It is a direct comparable peer in terms of company size, focus, and customer base.
• Teleflex: Teleflex manufactures a range of single-use and reusable medical devices for respiratory care and airway management, including neonatal applications. It is a direct comparable peer in medical device manufacturing for hospital respiratory workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/monivent

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds6 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monivent